Cargando…
Markers for Detection of Prostate Cancer
Early detection of prostate cancer is problematic, not just because of uncertainly whether a diagnosis will benefit an individual patient, but also as a result of the imprecise and invasive nature of establishing a diagnosis by biopsy. Despite its low sensitivity and specificity for identifying pati...
Autores principales: | Clarke, Raymond A., Schirra, Horst J., Catto, James W., Lavin, Martin F., Gardiner, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835122/ https://www.ncbi.nlm.nih.gov/pubmed/24281110 http://dx.doi.org/10.3390/cancers2021125 |
Ejemplares similares
-
Metabolomics: A Novel Approach to Early and Noninvasive Prostate Cancer Detection
por: Roberts, Matthew J., et al.
Publicado: (2011) -
Prostate-based biofluids for the detection of prostate cancer: A comparative study of the diagnostic performance of cell-sourced RNA biomarkers
por: Roberts, Matthew J., et al.
Publicado: (2016) -
New Genomic Structure for Prostate Cancer Specific Gene PCA3 within BMCC1: Implications for Prostate Cancer Detection and Progression
por: Clarke, Raymond A., et al.
Publicado: (2009) -
Seminal plasma enables selection and monitoring of active surveillance candidates using nuclear magnetic resonance-based metabolomics: A preliminary investigation
por: Roberts, Matthew J., et al.
Publicado: (2017) -
BMCC1 Is an AP-2 Associated Endosomal Protein in Prostate Cancer Cells
por: Harris, Janelle L., et al.
Publicado: (2013)